8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Eli Lilly filed an 8‑K on Feb 4, 2026 furnishing a press release (Exhibit 99.1).
Filed with the SEC on · Summarized by InvestorsBot
Eli Lilly filed an 8‑K on Feb 4, 2026 furnishing a press release (Exhibit 99.1). Investors should review the press release for company updates. 🗞️ $LLY #8K #SECfiling
The 8‑K also includes the Cover Page Inline XBRL file (Exhibit 104). Filing signed Feb 4, 2026 by Donald A. Zakrowski, SVP Finance & Chief Accounting Officer. 📄 $LLY #SECfiling #XBRL
Disclosure is limited to Item 9.01 (financial statements & exhibits); no other reportable items were included in this filing. ⚖️ $LLY #8K #SECfiling